Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Decibel Cannabis Company Inc. (DB.V)
CAD0.12
+0.01 (+4.35%)
CA TSXV Healthcare Drug Manufacturers - Specialty & Generic
Address
140 - 4th Avenue SW T2P 3N3
Calgary, AB, CA
Calgary, AB, CA
CEO
Benjamin Sze
Website
decibelcc.com
IPO
2019-03-04
ISIN CA2434371001
Also trades on
Other OTC · DBCCF (USD)
Toronto Stock Exchange Ventures · DB.V (CAD)
Description
Decibel Cannabis Company Inc. operates within Canada's cannabis industry, overseeing the entire spectrum from growing and processing to manufacturing and selling its diverse product line. It serves other licensed Canadian producers by supplying cannabis flower, pre-rolled offerings, and bulk biomass. Additionally, the company excels in the intricate processes of extracting, refining, and producing a variety of cannabis derivative goods, such as vape cartridges, edibles, and concentrated extracts. Consumers can find its products under proprietary labels including Qwest, Qwest Reserve, Blendcraft by Qwest, and General Admission. Decibel Cannabis Company Inc. has its corporate headquarters situated in Calgary, Canada.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CAD0.12
+0.01 (+4.35%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
232.3K
Beta
0.49
Float Shares
429.13M
Free Float %
74.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -3.85% | -3.85% | +25.00% | +8.70% | +13.64% | +92.31% | -7.41% | -59.68% | -96.59% | -96.59% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.12
Ratings Trend (MoM)
80% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.52
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+21.8% ★ Q1'26: +40.5% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%-123.0% Q1'26: +100.0% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-22.4% Q1'26: -49.0% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-15.5% Q1'26: -5.6% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-17.6% Q1'26: -5.9% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+35.4% Q1'26: +900.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-4.09× Q1'26: -762.87× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.24M
est: 4.81M (+29.5%)
|
29.93M
est: 28.80M (+3.9%)
|
52.45M
est: 53.15M (-1.3%)
|
79.33M
est: 80.15M (-1.0%)
|
106.22M
est: 105.60M (+0.6%)
|
92.54M
est: 92.44M (+0.1%)
|
112.72M
est: 115.13M (-2.1%)
|
132.73M
131.60M – 134.30M
+15.3% YoY
|
146.55M
140.10M – 154.20M
+10.4% YoY
|
155.80M
151.57M – 160.95M
+6.3% YoY
|
159.30M
154.98M – 164.56M
+2.2% YoY
|
168.30M
163.74M – 173.86M
+5.6% YoY
|
| EBITDA |
-5.44M
est: 331.4K (-1,741.3%)
|
-3.82M
est: 1.98M (-292.7%)
|
9.45M
est: 3.66M (+158.3%)
|
2.26M
est: 5.52M (-59.0%)
|
3.25M
est: 7.94M (-59.1%)
|
21.53M
est: 6.95M (+209.7%)
|
-10.81M
est: 8.66M (-224.8%)
|
9.98M
9.90M – 10.10M
+15.3% YoY
|
11.02M
10.54M – 11.60M
+10.4% YoY
|
11.72M
11.40M – 12.11M
+6.3% YoY
|
11.98M
11.66M – 12.38M
+2.2% YoY
|
12.66M
12.32M – 13.08M
+5.6% YoY
|
| EBIT |
-5.76M
est: 66.3K (-8,790.1%)
|
-6.22M
est: 396.7K (-1,668.4%)
|
5.83M
est: 732.0K (+696.8%)
|
-1.30M
est: 1.10M (-218.1%)
|
3.99M
est: 2.58M (+54.4%)
|
16.50M
est: 2.26M (+630.0%)
|
-17.42M
est: 2.81M (-718.8%)
|
3.24M
3.22M – 3.28M
+15.3% YoY
|
3.58M
3.42M – 3.77M
+10.4% YoY
|
3.81M
3.71M – 3.93M
+6.3% YoY
|
3.89M
3.79M – 4.02M
+2.2% YoY
|
4.11M
4.00M – 4.25M
+5.6% YoY
|
| Net Income |
-6.53M
est: -72.41M (+91.0%)
|
-9.21M
est: -8.52M (-8.1%)
|
1.74M
est: -2.13M (+181.8%)
|
-4.46M
est: 4.25M (-204.9%)
|
-1.77M
est: -669.4K (-164.4%)
|
9.46M
est: 1.45M (+553.7%)
|
-2.92M
est: 1.45M (-302.0%)
|
4.34M
4.17M – 4.51M
+200.0% YoY
|
13.39M
5.77M – 23.07M
+208.2% YoY
|
26.66M
11.54M – 28.85M
+99.2% YoY
|
17.31M
16.70M – 18.05M
-35.1% YoY
|
17.31M
16.70M – 18.05M
+0.0% YoY
|
| SGA |
5.33M
est: 1.68M (+217.4%)
|
14.79M
est: 10.04M (+47.3%)
|
18.05M
est: 18.54M (-2.6%)
|
23.08M
est: 27.95M (-17.4%)
|
30.91M
est: 32.93M (-6.1%)
|
29.92M
est: 28.83M (+3.8%)
|
34.90M
est: 35.90M (-2.8%)
|
41.39M
41.04M – 41.88M
+15.3% YoY
|
45.70M
43.69M – 48.08M
+10.4% YoY
|
48.58M
47.27M – 50.19M
+6.3% YoY
|
49.67M
48.33M – 51.32M
+2.2% YoY
|
52.48M
51.06M – 54.21M
+5.6% YoY
|
| EPS |
-0.10
est: -0.17 (+41.7%)
|
-0.03
est: -0.02 (-32.5%)
|
0.00
est: -0.01 (+196.0%)
|
-0.01
est: 0.01 (-210.0%)
|
0.00
est: 0.00 (-272.0%)
|
0.02
est: 0.00 (+788.0%)
|
-0.01
est: 0.00 (-304.0%)
|
0.01
0.01 – 0.01
+200.0% YoY
|
0.03
0.01 – 0.04
+233.3% YoY
|
0.03
0.02 – 0.05
+33.3% YoY
|
0.03
0.03 – 0.03
-10.0% YoY
|
0.03
0.03 – 0.03
+0.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-25 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
12.86M
OE per share TTM
0.01
Owner's Yield
17.83%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
98.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-101.8K
Shares Outstanding
576.86M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stuart Boucher | Chief Financial Officer | 337.7K | male |
| Benjamin Sze | Chief Executive Officer & Director | 305.7K | male |
| Adam Coates | Chief Revenue Officer | 289.7K | male |
| Jesse Martin | General Counsel & Corporate Secretary | — | — |
| Kris Newell | Chief Operating Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DB.V
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
